ANGO vs NOC · rev $292.5M vs P/E 17, rev $41.95B
AngioDynamics Inc (ANGO) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported NOC revenue for 2025-12-31 was $41.95B. Net income was $4.18B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
ANGO currently screens at market cap $378.5M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the ANGO and NOC stock pages for the full models.
Not investment advice.